Technical Analysis for AGTC - Applied Genetic Technologies Corporation

Grade Last Price % Change Price Change
grade D 3.68 -1.34% -0.05
AGTC closed down 1.34 percent on Friday, September 13, 2019, on 1.29 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical AGTC trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Resistance Bearish -1.34%
50 DMA Support Bullish -1.34%
1,2,3 Pullback Bullish Bullish Swing Setup -1.34%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.34%

Older signals for AGTC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. The company also completed preclinical proof-of-concept studies, and Phase I and Phase II clinical trials of a treatment for alpha-1 antitrypsin deficiency, an inherited orphan lung disease. In addition, it has proof-of-concept programs for other eye diseases, such as leber congenital amaurosis (type 2), and wet form of age-related macular degeneration. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.
Biotechnology Medical Specialties Diseases Gene Therapy Ophthalmology Age Related Macular Degeneration Vision Retinitis Pigmentosa Antitrypsin Deficiency Eye Diseases Gene Therapy Products X Linked Retinitis Pigmentosa Retinoschisis
Is AGTC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.5
52 Week Low 2.26
Average Volume 99,570
200-Day Moving Average 3.8199
50-Day Moving Average 3.5655
20-Day Moving Average 3.2115
10-Day Moving Average 3.526
Average True Range 0.289
ADX 28.31
+DI 21.8415
-DI 20.8179
Chandelier Exit (Long, 3 ATRs ) 3.1578
Chandelier Exit (Short, 3 ATRs ) 3.387
Upper Bollinger Band 3.9954
Lower Bollinger Band 2.4276
Percent B (%b) 0.8
BandWidth 48.818309
MACD Line 0.065
MACD Signal Line -0.04
MACD Histogram 0.105
Fundamentals Value
Market Cap 66.56 Million
Num Shares 18.1 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 5.84
Price-to-Sales 1.74
Price-to-Book 0.60
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.91
Resistance 3 (R3) 3.92 3.87 3.87
Resistance 2 (R2) 3.87 3.81 3.86 3.85
Resistance 1 (R1) 3.77 3.77 3.75 3.76 3.84
Pivot Point 3.72 3.72 3.70 3.71 3.72
Support 1 (S1) 3.62 3.66 3.60 3.61 3.52
Support 2 (S2) 3.57 3.62 3.56 3.51
Support 3 (S3) 3.47 3.57 3.49
Support 4 (S4) 3.46